Wei Wu, PhD

Wei Wu, PhD is a senior executive in the healthcare and biotechnology industry with extensive experience in venture investments and business development. Key details about Wei Wu include:

Professional Background

Wei Wu currently serves as Principal (Senior Director) of Venture Investments at Johnson & Johnson Innovation-JJDC, a position he has held since February 2021.1 In this role, he covers investments in biopharma and medical devices that align with Johnson & Johnson's strategic interests.

Board Positions

Wei Wu holds several board positions, including:

• Board Member at Shanghai Circode Biomed Co., Ltd (2023-present)1
• Board Observer at Hangzhou DAC Biotech Co., Ltd. (2022-present)1
• Previously served as Board Member at IMMPACT BIO USA INC (2021-2022)1

Previous Experience

Prior to his current role, Wei Wu's experience includes:

• Senior Associate at Illumina Ventures (2019-2021)1
• Director of Healthcare Investment and Business Development at BOE Technology Group (2017-2019)1
• Scientist and Project Lead at Tecan Genomics, Inc. (2015-2017)1

Education

Wei Wu completed his postdoctoral fellowship at Stanford University School of Medicine in the Gerald R. Crabtree Lab from January 2012 to July 2015.1 His educational background includes coursework in stem cell biology, next-generation sequencing, healthcare business, and finance.

Skills and Expertise

Wei Wu's expertise spans various areas including:

• Venture capital investments in healthcare
• Biopharma and medical device technologies
• Business development in the biotech sector
• Scientific research in genomics and therapeutics

His diverse background combines scientific knowledge with business acumen, making him well-suited for his current roles in venture investments and board positions in biotechnology companies.